
Tenet Healthcare (THC) Stock Forecast & Price Target
Tenet Healthcare (THC) Analyst Ratings
Bulls say
Tenet Healthcare's positive outlook is supported by its strategic investments in the USPI segment, which is characterized by faster growth and higher margins, leading to an anticipated improvement in return on invested capital (ROIC). The company's financial performance is expected to benefit from increased income from equity earnings and a favorable payer mix, alongside initiatives aimed at enhancing its cost structure. With strong demand and margin expansion projected, Tenet Healthcare is well-positioned to leverage its competitive advantages and capitalize on outpatient growth opportunities in the healthcare market.
Bears say
Tenet Healthcare's stock faces a negative outlook primarily due to anticipated headwinds from subsidy expirations, which are projected to impact revenues by $220 million in its Acute segment and $30 million in its USPI operations by 2026. Additionally, the potential loss of insurance coverage for 80-85% of affected individuals could lead to a decline in patient utilization, further exacerbating financial pressures. Despite previous non-recurring revenue boosts from Medicaid state payments, the company's valuation remains stagnant and disconnected from its underlying financial performance and ongoing deleveraging efforts.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Tenet Healthcare (THC) Analyst Forecast & Price Prediction
Start investing in Tenet Healthcare (THC)
Order type
Buy in
Order amount
Est. shares
0 shares